United Kingdom· GB-APID-38375511000001102
Kisqali 200mg tablets
A ribociclib product containing ribociclib, registered in United Kingdom by Originalis B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ribociclib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EF02 (ribociclib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Ribociclib · ATC L01EF02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ribociclib costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ribociclib · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$111.31
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ribociclib
- Manufacturer
- Originalis B.V.
- Country
- United Kingdom (GB)
- ATC code
- L01EF02
- ATC class
- Ribociclib
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin08719923005468
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
679 interactions on record for ribociclib.
Graded by severity as the source publishes them — 315 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ribociclib · interactions on record
679 records
- 315 severe
- 347 moderate
- 17 minor
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ribociclib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandKisqali
- CanadaKISQALINOVARTIS PHARMACEUTICALS CANADA INC
- CzechiaKISQALINovartis Europharm Limited, Dublin
- United StatesKISQALINovartis Pharmaceuticals Corporation
- SpainKISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- BelgiumKisqali 200 mgNovartis Europharm
- IrelandKisqali 200 mg film-coated tabletsNovartis Europharm Limited
- IcelandKisqaliNovartis Europharm Limited*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kisqali
- Liechtenstein · Kisqali
- Norway · Kisqali
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4c5e0458-99c7-4c61-859b-0b68152490b2 GET /v1/drugs/4c5e0458-99c7-4c61-859b-0b68152490b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38375511000001102",
"desc": "Kisqali 200mg tablets (Originalis B.V.)",
"form": "Oral tablet",
"vpid": "34814111000001103",
"source": "dmd",
"vtm_id": "777435007",
"strength": "200 mg",
"substance": "Ribociclib",
"ingredient": "Ribociclib succinate",
"supplier_code": "36751511000001108"
}See everything about ribociclib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.